Patients with IgA nephropathy and severe proteinuria have a high lifetime risk of kidney failure. The efficacy and safety of the selective endothelin type A receptor antagonist atrasentan in reducing proteinuria in patients with IgA nephropathy are incompletely understood.
美好乐松
迟大猫
Grayball
Singularity
爱静静
MchemG
iNk
back you up
Loooong
今天只做一件事
VDC
cdercder
开心岩
迷人秋烟
昏睡的蟠桃
劲秉
归尘
王文静
shhoing
yanzu
皖公网安备34019202002308
